Banner

Serum YKL40: A novel potential link between inflammation and dyslipidemia in acne vulgaris

• 2019
العودة
معلومات البحث
المؤلفون Adel Ebrahim MD1 | Amany Ibrahim Mustafa MD1 | Ola Samir El‐Shimi MD2 | Mai Abdallah Fathy MBBCh3
الكلمات المفتاحية acne vulgaris, dyslipidemia, YKL‐40
المجلة العلمية Not Available
الناشر Not Available
المجلد Not Available
العدد Not Available
الصفحات Not Available
publication.type International
رابط البحث Not Available
المواد المرفقة Not Available
الملخص
Background: Acne vulgaris (AV) is an inflammatory skin disorder that may be associated
with metabolic disorders. The relation between lipid profile in acne is not widely
investigated. Chitinase‐3‐like protein 1 (YKL‐40) has been found to be implicated in
different inflammatory conditions.
Aims: We aimed at investigating the role YKL‐40 in acne pathogenesis and associated
dyslipidemia in acne patients.
Patients/Methods: This study included 50 acne vulgaris patients and 30 matched
control subjects. Serum YKL‐40 in addition to lipid profile were assessed in all studied
subjects.
Results: Serum YKL‐40 level was significantly elevated in acne patients than healthy
controls (P < .001). We also found a significant positive correlations between serum
YKL‐40, serum TGs, TC, and LDL‐C (P value: .022, .001, .017 respectively) while, a
significant negative correlation between serum YKL‐40 and HDL‐c (P value: .036)
was detected.
Conclusion: Our study results suggest that YKL‐40 might have a role in AV pathogenesis.
In addition, it could provide a new potential link between inflammation and
dyslipidemia observed in acne patients.